J&J expands cancer portfolio with $3.05 billion Halda buy – Reuters

  1. J&J expands cancer portfolio with $3.05 billion Halda buy  Reuters
  2. Johnson & Johnson acquires Halda Therapeutics for $3 billion, a big win for a buzzy new technology  statnews.com
  3. Halda Therapeutics Announces Acquisition by Johnson & Johnson  GlobeNewswire
  4. J&J to buy cancer therapy developer Halda Therapeutics for $3.05 billion  MarketScreener
  5. J&J to acquire Halda Therapeutics for $3.1B  breakingthenews.net

Continue Reading